Filing Details
- Accession Number:
- 0001127602-13-034689
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-12-16 16:01:38
- Reporting Period:
- 2013-12-12
- Filing Date:
- 2013-12-16
- Accepted Time:
- 2013-12-16 16:01:38
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
859737 | Hologic Inc | HOLX | X-Ray Apparatus & Tubes & Related Irradiation Apparatus (3844) | 042902449 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1190845 | H Robert Lavallee | 35 Crosby Drive Bedford MA 01730 | Svp, Chief Accounting Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-12-12 | 10,000 | $4.96 | 22,741 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-12-12 | 10,000 | $21.71 | 12,741 | No | 4 | S | Direct | |
Common Stock | Disposition | 2013-12-12 | 4,277 | $21.70 | 12,741 | No | 4 | S | Direct | |
Common Stock | Disposition | 2013-12-13 | 1,400 | $21.67 | 11,341 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2013-12-12 | 10,000 | $0.00 | 10,000 | $4.96 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2005-03-01 | 2014-03-01 | No | 4 | M | Direct |
Footnotes
- The transaction reported herein reflects an aggregate of sales at prices ranging from $21.67 to $21.68, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full disclosure with respect to the number of shares sold at each separate price.